1-5 of 5
Elaine Majerus
Close
Sort by
Journal Articles

Health-Related Quality of Life Following Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A in the Phase 3 Trial GENEr8-1

Brian O'Mahony, Johnny Mahlangu, Kathelijne Peerlinck, Jiaan-Der Wang, Gillian Lowe, Chee Wee Tan, Adam Giermasz, Huyen A Tran, Teh-Liane Khoo, Erin Cockrell, Dominic Pepperell, Hervé Chambost, María Fernanda López Fernández, Rashid Kazmi, Elaine Majerus, Mark W Skinner, Robert Klamroth, Jennifer Quinn, Hua Yu, Wing Yen Wong, Adebayo Lawal, Tara M Robinson, Benjamin Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 4916.
https://doi.org/10.1182/blood-2021-146021
Published: 2021
Journal Articles

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Margaret V. Ragni, MD MPH, Craig D. Seaman, MD MS, Diana Gilligan, MD, Claire S. Philipp, MD, Anne T. Neff, MD, Robert F. Sidonio, Jr., MD MSc, Philip Kuriakose, MD, Tzu-Fei Wang, MD MPH, Lynn M. Malec, MD, Rajiv K. Pruthi, MBBS, Elaine Majerus, MD PhD, George M. Rodgers, MD PhD, Danielle Nance, MD, Nina Hwang, MD, Barbara A. Konkle, MD, Andrew D. Leavitt, MD, Joseph Lasky, MD, Allison P. Wheeler, MD, Roshni Kulkarni, MD, Tammuella Singleton, MD, Dana Ivanco, Elynna Youm, BA, Glory Koerbel, MSN, RN, Scott Rothenberger, PhD, Doris M. Rubio, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1130.
https://doi.org/10.1182/blood-2019-124234
Published: 2019
Journal Articles

A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients

Joshua J. Field, MD, MS, Kenneth I. Ataga, MD, Elaine Majerus, MD, PhD, Cheryl A. Eaton, BA, Robert Mashal, MD, David G. Nathan, MD
Journal: Blood
Blood (2013) 122 (21): 977.
https://doi.org/10.1182/blood.V122.21.977.977
Published: 2013
Journal Articles

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Clinical Trials & Observations
Joshua J. Field, Gene Lin, Maureen M. Okam, Elaine Majerus, Jeffrey Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan
Journal: Blood
Blood (2013) 121 (17): 3329–3334.
https://doi.org/10.1182/blood-2012-11-465963
Published: 2013
Includes: Supplemental data
Journal Articles

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Joshua Field, MD, MS, Gene Lin, MD, PhD, Maureen Okam, MD, MPH, Elaine Majerus, MD, PhD, Onyinye Onyekwere, MD, MS, Ainsley Ross, BA, Donna Neuberg, ScD, Federico Campigotto, MS, David G. Nathan, MD, Joel Linden, PhD
Journal: Blood
Blood (2011) 118 (21): 849.
https://doi.org/10.1182/blood.V118.21.849.849
Published: 2011